442
Views
33
CrossRef citations to date
0
Altmetric
Articles

In vitro and in situ experiments to evaluate the biodistribution and cellular toxicity of ultrasmall iron oxide nanoparticles potentially used as oral iron supplements

, , , , , , , & show all
Pages 388-403 | Received 03 Jul 2019, Accepted 27 Dec 2019, Published online: 20 Jan 2020

References

  • Alleyne, M., M. K. Horne, and J. L. Miller. 2008. “Individualized Treatment for Iron-Deficiency Anemia in Adults.” American Journal of Medicine 121 (11): 943–948. doi:10.1016/j.amjmed.2008.07.012.
  • Alphandéry, E. 2019. “Biodistribution and Targeting Properties of Iron Oxide Nanoparticles for Treatments of Cancer and Iron Anemia Disease.” Nanotoxicology 13 (5): 573–596. doi:10.1080/17435390.2019.1572809.
  • Arruebo, M., R. Fernández-Pacheco, M. R. Ibarra, and J. Santamaría. 2007. “Magnetic Nanoparticles for Drug Delivery.” Nano Today 2 (3): 22–32. doi:10.1016/S1748-0132(07)70084-1.
  • Auerbach, M., and H. Ballard. 2010. “Clinical Use of Intravenous Iron: Administration, Efficacy, and Safety.” Hematology 2010 (1): 338–347. doi:10.1182/asheducation-2010.1.338.
  • Bobo, D., K. J. Robinson, J. Islam, K. J. Thurecht, and S. R. Corrie. 2016. “Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date.” Pharmaceutical Research 33 (10): 2373–2387. doi:10.1007/s11095-016-1958-5.
  • Collins, A. 2004. “The Comet Assay for DNA Damage and Repair.” Molecular Biotechnology 26 (3): 249–261. doi:10.1385/MB:26:3:249.
  • de Angelis, I., and L. Turco. 2011. “Caco-2 Cells as a Model for Intestinal Absorption.” Current Protocols in Toxicology 47 (1). doi:10.1002/0471140856.tx2006s47.
  • Dostal, A., C. Chassard, F. M. Hilty, M. B. Zimmermann, T. Jaeggi, S. Rossi, and C. Lacroix. 2011. “Iron Depletion and Repletion with Ferrous Sulfate or Electrolytic Iron Modifies the Composition and Metabolic Activity of the Gut Microbiota in Rats.” The Journal of Nutrition 142 (2): 271–277. doi:10.3945/jn.111.148643.
  • Escribano, E., X. G. Sala, J. Salamanca, C. R. Navarro, and J. Q. Regué. 2012. “Single-Pass Intestinal Perfusion to Establish the Intestinal Permeability of Model Drugs in Mouse.” International Journal of Pharmaceutics 436 (1–2): 472–477. doi:10.1016/j.ijpharm.2012.07.010.
  • Fernández, J. G., C. Sánchez-González, J. Bettmer, J. Llopis, N. Jakubowski, U. Panne, and M. Montes-Bayón. 2018. “Quantitative Assessment of the Metabolic Products of Iron Oxide Nanoparticles to Be Used as Iron Supplements in Cell Cultures.” Analytica Chimica Acta 1039: 24–30. doi:10.1016/j.aca.2018.08.003.
  • Gamboa, J. M., and K. W. Leong. 2013. “In Vitro and In Vivo Models for the Study of Oral Delivery of Nanoparticles.” Advanced Drug Delivery Reviews 65 (6): 800–810. doi:10.1016/j.addr.2013.01.003.
  • Ganz, T., and E. Nemeth. 2011. “Hepcidin and Disorders of Iron Metabolism.” Annual Review of Medicine 62 (1): 347–360. doi:10.1146/annurev-med-050109-142444.
  • García-Fernández, J., J. Bettmer, N. Jakubowski, U. Panne, E. Añón, M. Montes-Bayón, and A. Sanz-Medel. 2017. “The Fate of Iron Nanoparticles Used for Treatment of Iron Deficiency in Blood Using Mass-Spectrometry Based Strategies.” Microchimica Acta 184 (10): 3673–3680. doi:10.1007/s00604-017-2388-8.
  • Gómez-Ayala, A. E., M. S. Campos, I. López-Aliaga, I. Pallarés, S. Hartiti, M. Barrionuevo, M. J. Alférez, C. R. -M. María, and F. Lisbona. 1997. “Effect of Source of Iron on Duodenal Absorption of Iron, Calcium, Phosphorus, Magnesium, Copper and Zinc in Rats with Ferropoenic Anaemia.” International Journal for Vitamin and Nutrition Research 67 (2):106–114.
  • Gulec, S., G. J. Anderson, and J. F. Collins. 2014. “Mechanistic and Regulatory Aspects of Intestinal Iron Absorption.” American Journal of Physiology-Gastrointestinal and Liver Physiology 307 (4): G397–G409. doi:10.1152/ajpgi.00348.2013.
  • Hilty, F. M, M. Arnold, M. Hilbe, A. Teleki, J. T. N. Knijnenburg, F. Ehrensperger, R. F. Hurrell, S. E. Pratsinis, W. Langhans, and M. B. Zimmermann. 2010. “Iron from Nanocompounds Containing Iron and Zinc Is Highly Bioavailable in Rats Without Tissue Accumulation.” Nature Nanotechnology 5 (5): 374–380. doi:10.1038/nnano.2010.79.
  • Jahn, M. R., H. B. Andreasen, S. Fütterer, T. Nawroth, V. Schünemann, U. Kolb, W. Hofmeister, et al. 2011. “A Comparative Study of the Physicochemical Properties of Iron Isomaltoside 1000 (Monofer®), a New Intravenous Iron Preparation and Its Clinical Implications.” European Journal of Pharmaceutics and Biopharmaceutics 78 (3): 480–491. doi:10.1016/j.ejpb.2011.03.016.
  • Lopez-Chaves, C., J. Soto-Alvaredo, M. Montes-Bayon, J. Bettmer, J. Llopis, and C. Sanchez-Gonzalez. 2018. “Gold Nanoparticles: Distribution, Bioaccumulation and Toxicity. In Vitro and In Vivo Studies.” Nanomedicine: Nanotechnology, Biology, and Medicine 14 (1): 1–12. doi:10.1016/j.nano.2017.08.011.
  • Martínez-Maqueda, D., B. Miralles, and I. Recio. 2015. “HT29 Cell Line.” In The Impact of Food Bioactives on Health: In Vitro and Ex Vivo Models, edited by K. Verhoeckx, P. Cotter, I. López-Expósito, C. Kleiveland, T. Lea, A. Mackie, T. Requena, D. Swiatecka, H. Wichers, 113–124. Cham: Springer. doi:10.1007/978-3-319-16104-4_11.
  • Mornet, S., S. Vasseur, F. Grasset, and E. Duguet. 2004. “Magnetic Nanoparticle Design for Medical Diagnosis and Therapy.” Journal of Materials Chemistry 14 (14): 2161. doi:10.1039/b402025a.
  • Nollevaux, G., C. Devillé, B. El Moualij, W. Zorzi, P. Deloyer, Y. J. Schneider, O. Peulen, and G. Dandrifosse. 2006. “Development of a Serum-Free Co-Culture of Human Intestinal Epithelium Cell-Lines (Caco-2/HT29-5M21).” BMC Cell Biology 7 (1): 20.
  • O’Dell, B. L. 1997. Handbook of Nutritionally Essential Minerals Elements. New York: Maecel Dekker.
  • Pallarés, I., F. Lisbona, I. Lopez Aliaga, M. Barrionuevo, M. J. M. Alférez, and M. S. Campos. 1993. “Effect of Iron Deficiency on the Digestive Utilization of Iron, Phosphorus, Calcium and Magnesium in Rats.” British Journal of Nutrition 70 (2): 609–620. doi:10.1079/BJN19930152.
  • Pereira, D. I. A., S. F. A. Bruggraber, N. Faria, L. K. Poots, M. A. Tagmount, M. F. Aslam, D. M. Frazer, C. D. Vulpe, G. J. Anderson, J. J. Powell. 2014. “Nanoparticulate Iron(III) Oxo-Hydroxide Delivers Safe Iron That Is Well Absorbed and Utilised in Humans.” Nanomedicine: Nanotechnology, Biology, and Medicine 10 (8): 1877–1886. doi:10.1016/j.nano.2014.06.012.
  • Porter, J. B., R. D. Abeysinghe, L. Marshall, R. C. Hider, and S. Singh. 1996. “Kinetics of Removal and Reappearance of Non-Transferrin-Bound Plasma Iron with Deferoxamine Therapy.” Blood 88 (2): 705–713. doi:10.1182/blood.V88.2.705.bloodjournal882705.
  • Powell, J. J., S. F. Bruggraber, N. Faria, L. K. Poots, N. Hondow, T. J. Pennycook, G. O. Latunde-Dada, R. J. Simpson, A. P. Brown, D. I. Pereira. 2014. “A Nano-Disperse Ferritin-Core Mimetic That Efficiently Corrects Anemia Without Luminal Iron Redox Activity.” Nanomedicine: Nanotechnology, Biology, and Medicine 10 (7): 1529–1538. doi:10.1016/j.nano.2013.12.011.
  • Roos, C., D. Dahlgren, S. Berg, J. Westergren, B. Abrahamsson, C. Tannergren, E. Sjögren, and H. Lennernäs. 2017. “In Vivo Mechanisms of Intestinal Drug Absorption from Aprepitant Nanoformulations.” Molecular Pharmaceutics 14 (12): 4233–4242. doi:10.1021/acs.molpharmaceut.7b00294.
  • Sambuy, Y., I. De Angelis, G. Ranaldi, M. L. Scarino, A. Stammati, and F. Zucco. 2005. “The Caco-2 Cell Line as a Model of the Intestinal Barrier: Influence of Cell and Culture-Related Factors on Caco-2 Cell Functional Characteristics.” Cell Biology and Toxicology 21 (1): 1–26. doi:10.1007/s10565-005-0085-6.
  • Sánchez-González, C., C. López-Chaves, C. E. Trenzado, P. Aranda, M. López-Jurado, J. Gómez-Aracena, M. Montes-Bayón, A. Sanz-Medel, and J. Llopis. 2014. “Changes in Iron Metabolism and Oxidative Status in STZ-Induced Diabetic Rats Treated with Bis(Maltolato) Oxovanadium (IV) as an Antidiabetic Agent.” The Scientific World Journal 2014: 1–6. doi:10.1155/2014/706074.
  • Sanchez-Morito, N., E. Planells, P. Aranda, and J. Llopis. 2000. “Influence of Magnesium Deficiency on the Bioavailability and Tissue Distribution of Iron in the Rat.” Journal of Nutritional Biochemistry 11 (2):103-108. doi:10.1016/S0955-2863(99)00076-5.
  • Shang, L., K. Nienhaus, and G. U. Nienhaus. 2014. “Engineered Nanoparticles Interacting with Cells: Size Matters.” Journal of Nanobiotechnology 12 (1): 5. doi:10.1186/1477-3155-12-5.
  • Sinnecker, H., T. Krause, S. Koelling, I. Lautenschläger, and A. Frey. 2014. “The Gut Wall Provides an Effective Barrier against Nanoparticle Uptake.” Beilstein Journal of Nanotechnology 5: 2092–2101. doi:10.3762/bjnano.5.218.
  • Tolkien, Z., L. Stecher, A. P. Mander, D. I. A. Pereira, and J. J. Powell. 2015. “Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta-Analysis.” PLoS ONE 10 (2): e0117383. doi:10.1371/journal.pone.0117383.
  • Turiel-Fernández, D., J. Bettmer, and M. Montes-Bayón. 2018. “Evaluation of the Uptake, Storage and Cell Effects of Nano-Iron in Enterocyte-Like Cell Models.” Journal of Trace Elements in Medicine and Biology 49: 98–104. doi:10.1016/j.jtemb.2018.05.002.
  • Wang, B., J. Jie Yin, X. Zhou, I. Kurash, Z. Chai, Y. Zhao, and W. Feng. 2013. “Physicochemical Origin for Free Radical Generation of Iron Oxide Nanoparticles in Biomicroenvironment: Catalytic Activities Mediated by Surface Chemical States.” Journal of Physical Chemistry C 117 (1): 383–392. doi:10.1021/jp3101392.
  • Wang, S., R. Su, S. Nie, M. Sun, J. Zhang, D. Wu, and N. Moustaid-Moussa. 2014. “Application of Nanotechnology in Improving Bioavailability and Bioactivity of Diet-Derived Phytochemicals.” Journal of Nutritional Biochemistry 25 (4): 363–376. doi:10.1016/j.jnutbio.2013.10.002.
  • Zakeri-Milani, P., H. Valizadeh, H. Tajerzadeh, Y. Azarmi, Z. Islambolchilar, S. Barzegar, and M. Barzegar-Jalali. 2007. “Predicting Human Intestinal Permeability Using Single-Pass Intestinal Perfusion to Rat.” Journal of Pharmacy and Pharmaceutical Sciences 10 (3): 368–379.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.